Human Galectin-3 Quantikine ELISA Kit
| Name | Human Galectin-3 Quantikine ELISA Kit |
|---|---|
| Supplier | R&D Systems |
| Catalog | DGAL30 |
| Category | ELISA Kit |
| Prices | $519.00, $2,491.00, $16,868.00 |
| Sizes | 1 kit, 1 pack (6 Plates), 1 pack (50 Plates) |
| Assay Type | Solid Phase Sandwich ELISA |
| Sample Type | Cell Culture Supernates (50 uL), Serum (50 uL), EDTA Plasma (50 uL), Heparin Plasma (50 uL) |
| Sensitivity | 0.085 ng/mL |
| Range | 0.3 - 10 ng/mL (Cell Culture Supernates, Serum, EDTA Plasma, Heparin Plasma) |
| Format | 96-well strip plate |
| Applications | ELISA |
| Species Reactivities | Human |
| Description | The Quantikine Human Galectin-3 Immunoassay is a 4.5 hour solid phase ELISA designed to measure Galectin-3 levels in cell culture supernates, serum, and plasma |
| Gene | LGALS3 |
| Supplier Page | Shop |
Product images
Product References
Serum Galectin-3 and ST2 as predictors of unfavorable outcome in stable dilated - Serum Galectin-3 and ST2 as predictors of unfavorable outcome in stable dilated
Wojciechowska C, Romuk E, Nowalany-Kozielska E, Jachec W. Hellenic J Cardiol. 2017 Mar 28. pii: S1109-9666(16)30249-4. doi:
Serum levels of galectin-1, galectin-3, and galectin-9 are associated with large - Serum levels of galectin-1, galectin-3, and galectin-9 are associated with large
He XW, Li WL, Li C, Liu P, Shen YG, Zhu M, Jin XP. Sci Rep. 2017 Jan 23;7:40994.
Aldosterone induced galectin-3 secretion in vitro and in vivo: from cells to - Aldosterone induced galectin-3 secretion in vitro and in vivo: from cells to
Lin YH, Chou CH, Wu XM, Chang YY, Hung CS, Chen YH, Tzeng YL, Wu VC, Ho YL, Hsieh FJ, Wu KD. PLoS One. 2014 Sep 2;9(9):e95254.
Hypoxia potentiates glioma-mediated immunosuppression. - Hypoxia potentiates glioma-mediated immunosuppression.
Wei J, Wu A, Kong LY, Wang Y, Fuller G, Fokt I, Melillo G, Priebe W, Heimberger AB. PLoS One. 2011 Jan 20;6(1):e16195.
Galectin-3 in cord blood of term and preterm infants. - Galectin-3 in cord blood of term and preterm infants.
Demmert M, Faust K, Bohlmann MK, Troger B, Gopel W, Herting E, Hartel C. Clin Exp Immunol. 2012 Feb;167(2):246-51.